RXO Forecast, price target & analysts
RXO Target price 2025 - Analyst rating & recommendation
RXO Classifications & Recommendation:
RXO Price Target
| Target Price | $17.34 |
| Price | $10.86 |
| Potential |
59.67%
register free of charge
|
| Number of Estimates | 20 |
|
20 Analysts have issued a price target RXO 2026 .
The average RXO target price is $17.34.
This is
59.67%
register free of charge
$23.10
112.71%
register free of charge
$11.11
2.30%
register free of charge
|
|
| A rating was issued by 26 analysts: 7 Analysts recommend RXO to buy, 16 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the RXO stock has an average upside potential 2026 of
59.67%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.55 | 5.92 |
| 15.86% | 30.18% | |
| EBITDA Margin | 2.59% | 2.48% |
| 24.56% | 4.37% | |
| Net Margin | -6.37% | 0.32% |
| 6,357.31% | 105.02% |
23 Analysts have issued a sales forecast RXO 2025 . The average RXO sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an RXO EBITDA forecast 2025. The average RXO EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
23 RXO Analysts have issued a net profit forecast 2025. The average RXO net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.17 | 0.12 |
| 7,333.33% | 105.53% | |
| P/E | 92.65 | |
| EV/Sales | 0.36 |
23 Analysts have issued a RXO forecast for earnings per share. The average RXO EPS is
This results in the following potential growth metrics and future valuations:
Current RXO Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Susquehanna |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Oct 10 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Oct 09 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Susquehanna:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Oct 10 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Oct 09 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
